Patient Registry of Roflumilast In Real Life

Trial Profile

Patient Registry of Roflumilast In Real Life

Phase of Trial: Phase IV

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 05 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 15 Jan 2016 Planned End Date changed from 1 Jan 2016 to 1 Apr 2016 as per record.
    • 15 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016 as per record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top